Recombinant multi-species TNNI3/ CMD1FF/ CMD2A protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Target products collectionGo to TNNI3/TNNI3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TNNI3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.

The target: TNNI3, gene name: TNNI3, also named as CMD1FF, CMD2A, CMH7, RCM1, TNNC1, cTnI. Troponin I (TnI), along with troponin T (TnT) and troponin C (TnC), is one of 3 subunits that form the troponin complex of the thin filaments of striated muscle. TnI is the inhibitory subunit; blocking actin-myosin interactions and thereby mediating striated muscle relaxation. The TnI subfamily contains three genes: TnI-skeletal-fast-twitch, TnI-skeletal-slow-twitch, and TnI-cardiac. This gene encodes the TnI-cardiac protein and is exclusively expressed in cardiac muscle tissues. Mutations in this gene cause familial hypertrophic cardiomyopathy type 7 (CMH7) and familial restrictive cardiomyopathy (RCM). Troponin I is useful in making a diagnosis of heart failure, and of ischemic heart disease. An elevated level of troponin is also now used as indicator of acute myocardial injury in patients hospitalized with moderate/severe Coronavirus Disease 2019 (COVID-19). Such elevation has also been associated with higher risk of mortality in cardiovascular disease patients hospitalized due to COVID-19. [provided by RefSeq, Aug 2020].

Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research.Please click inquiry for product quotation. → Inquiry

Catalog No.Product NameSpeciesSizePrice
GM-Tg-hg-T20186-Ag-1Human TNNI3 proteinHuman1mg/10mg/100mg/≥100mgInquiry
GM-Tg-rg-T20186-Ag-1Rat TNNI3 proteinRat1mg/10mg/100mg/≥100mgInquiry
GM-Tg-mg-T20186-Ag-1Mouse TNNI3 proteinMouse1mg/10mg/100mg/≥100mgInquiry
GM-Tg-cynog-T20186-Ag-1Cynomolgus/ Rhesus macaque TNNI3 proteinCynomolgus/
Rhesus macaque
1mg/10mg/100mg/≥100mgInquiry
GM-Tg-felg-T20186-Ag-1Feline TNNI3 proteinFeline1mg/10mg/100mg/≥100mgInquiry
GM-Tg-cang-T20186-Ag-1Canine TNNI3 proteinCanine1mg/10mg/100mg/≥100mgInquiry
GM-Tg-bovg-T20186-Ag-1Bovine TNNI3 proteinBovine1mg/10mg/100mg/≥100mgInquiry
GM-Tg-bovg-T20186-Ag-1Equine TNNI3 proteinEquine1mg/10mg/100mg/≥100mgInquiry
Shipping Cost:760.00



Description

Catalog No.GM-Tg-hg-T20186-Ag, GM-Tg-rg-T20186-Ag, GM-Tg-mg-T20186-Ag, GM-Tg-cynog-T20186-Ag,
GM-Tg-felg-T20186-Ag, GM-Tg-cang-T20186-Ag, GM-Tg-bovg-T20186-Ag, GM-Tg-equg-T20186-Ag-1
Products Name TNNI3 protein
SpeciesHuman, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target NameTNNI3
Protein Sub-locationIntrocelluar Protein
IsotypesRecombinant protein
Expression platform Mammalian cell
Bioactivity validationAffintiy&bioactivity validated by ELISA, cell culture validated.
TagHis
Products descriptionRecombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TNNI3 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
PurityPurity: ≥95% (SDS-PAGE)
ApplicationIn vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
FormulationSupplied as a 0.2 μM filtered solution of PBS, PH7.4.
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.